Exhibit 107
Calculation of Filing Fee Tables
FORM F-3
…………..
(Form Type)
NLS Pharmaceutics Ltd.
……………………………………………………..…
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| | Security
Type | Security
Class
Title | Fee
Calculation
or Carry
Forward
Rule | Amount
Registered | Proposed
Maximum
Offering
Price Per
Unit | Maximum
Aggregate
Offering
Price | Fee
Rate | Amount of
Registration
Fee | Carry
Forward
Form
Type | Carry
Forward
File
Number | Carry
Forward
Initial
effective
date | Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward |
| Newly Registered Securities | | | | |
Fees to Be Paid | Equity | Common Shares | Rule 457(o) | (1) (3) | (2) | | | | | | | |
| | Equity | Warrants | | | | | | | | | | |
| | Equity | Units | | | | | | | | | | |
| | Unallocated Shelf | | | | | $75,000,000 | $0.0000927 | $6,952.50 | | | | |
Fees Previously Paid | | | | | | | | | | | | |
| | | | | |
| | Total Offering Amounts | | $75,000,000 | | $6,952.50 | | | | |
| | Total Fees Previously Paid | | | | $0.00 | | | | |
| | Total Fee Offsets | | | | $0.00 | | | | |
| | Net Fee Due | | | | $6,952.50 | | | | |
| (1) | There are being registered under this registration statement such indeterminate number of securities as may be sold by the registrant from time to time, which collectively shall have an aggregate initial offering price not to exceed $75,000,000. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the common shares being registered hereunder include such indeterminate number of common shares as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends, or similar transactions. |
| (2) | Estimated solely for purposes of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act. |
| (3) | Omitted pursuant to Rule 457(o) under the Securities Act. |
